Pluri Inc. Public Float
Pluri Inc. (PLUR) had Public Float of $15.19 million as of 2025-12-31, per its 10-K filed 2026-09-10.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-09-10
- 2025-12-31: Entity Public Float $15.19M.
- 2024-12-31: Entity Public Float $22.21M.
- 2023-12-31: Entity Public Float $22.86M.
- 2022-12-31: Entity Public Float $34.41M.
| Period end | Entity Public Float |
|---|---|
| 2025-12-31 | $15.19M 10-K · filed 2026-09-10 |
| 2024-12-31 | $22.21M 10-K · filed 2025-09-17 |
| 2023-12-31 | $22.86M 10-K · filed 2024-09-18 |
| 2022-12-31 | $34.41M 10-K · filed 2023-09-12 |
| 2021-12-31 | $44.89M 10-K · filed 2022-09-21 |
| 2020-12-31 | $174.93M 10-K · filed 2021-09-13 |
| 2019-12-31 | $62.30M 10-K · filed 2020-09-10 |
| 2018-12-31 | $85.20M 10-K · filed 2019-09-12 |
| 2017-12-31 | $140.86M 10-K · filed 2018-09-12 |
| 2016-12-31 | $107.97M 10-K · filed 2017-09-07 |
| 2015-12-31 | $84.30M 10-K · filed 2016-09-07 |
| 2014-12-31 | $164.53M 10-K · filed 2015-09-09 |
| 2013-12-31 | $214.20M 10-K · filed 2014-09-11 |
| 2012-12-31 | $176.35B 10-K · filed 2013-09-11 |
| 2012-06-30 | $104.69M 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |